Uncategorized

Physician-Directed Weight Loss

As one of the only pharmaceutical wholesalers specializing in clinic dispensing, PCA offers a collection of products and services to help you serve your patients. Our bariatric clinic customers offer a suite of services including medication options for patients looking to lose weight.  PCA offers prepackaged products like phentermine, phendimetrazine, metformin and tretinoin cream to provide to your patients.

Tracking dispensed medications can sometimes be a challenge.  PCA offers medication tracking software and a dispensing logbook solution to make it easier to keep track of inventory and dispensing activities.  Easy-to-use reporting features make it simple to create reports for regulatory submission or clinic management purposes.  Cost for the software?  None.  We provide the software to our clinic customers as part of our solution.

Part of the PCA service difference is maintaining inventory of the medications you use so we can ship them the day you order.  Our centralized location allows us to get shipments to any corner of the United States in a few days and next day delivery to many locations.  Give us a call and let’s talk about how we can help you make dispensing work in your clinic.

Schedule a free claims analysis now.

Let’s Talk now

Leader in AI-driven health benefits navigation Healthee partners with Northwind

Katherine Lurk | Mar 28th, 2025
A game-changer for employers looking to cut costs and gain control With healthcare costs continuing to rise, employers are seeking new ways to rein in spending without sacrificing the quality of benefits. This partnership enables Healthee clients to optimize prescription drug management, reducing costs through preferable generic drug pricing, high-touch chronic care programs, and more. … more »

continue reading

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading